Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
Title: | Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations |
---|---|
Authors: | Carme Camps, Nayia Petousi, Celeste Bento, Holger Cario, Richard R. Copley, Mary Frances McMullin, Richard van Wijk, Peter J. Ratcliffe, Peter A. Robbins, Jenny C. Taylor |
Source: | Haematologica, Vol 101, Iss 11 (2016) |
Publisher Information: | Ferrata Storti Foundation, 2016. |
Publication Year: | 2016 |
Collection: | LCC:Diseases of the blood and blood-forming organs |
Subject Terms: | Diseases of the blood and blood-forming organs, RC633-647.5 |
More Details: | Erythrocytosis is a rare disorder characterized by increased red cell mass and elevated hemoglobin concentration and hematocrit. Several genetic variants have been identified as causes for erythrocytosis in genes belonging to different pathways including oxygen sensing, erythropoiesis and oxygen transport. However, despite clinical investigation and screening for these mutations, the cause of disease cannot be found in a considerable number of patients, who are classified as having idiopathic erythrocytosis. In this study, we developed a targeted next-generation sequencing panel encompassing the exonic regions of 21 genes from relevant pathways (~79 Kb) and sequenced 125 patients with idiopathic erythrocytosis. The panel effectively screened 97% of coding regions of these genes, with an average coverage of 450×. It identified 51 different rare variants, all leading to alterations of protein sequence, with 57 out of 125 cases (45.6%) having at least one of these variants. Ten of these were known erythrocytosis-causing variants, which had been missed following existing diagnostic algorithms. Twenty-two were novel variants in erythrocytosis-associated genes (EGLN1, EPAS1, VHL, BPGM, JAK2, SH2B3) and in novel genes included in the panel (e.g. EPO, EGLN2, HIF3A, OS9), some with a high likelihood of functionality, for which future segregation, functional and replication studies will be useful to provide further evidence for causality. The rest were classified as polymorphisms. Overall, these results demonstrate the benefits of using a gene panel rather than existing methods in which focused genetic screening is performed depending on biochemical measurements: the gene panel improves diagnostic accuracy and provides the opportunity for discovery of novel variants. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 0390-6078 1592-8721 |
Relation: | https://haematologica.org/article/view/7874; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721 |
DOI: | 10.3324/haematol.2016.144063 |
Access URL: | https://doaj.org/article/b77919d6ea97452791616dfef1c814cd |
Accession Number: | edsdoj.b77919d6ea97452791616dfef1c814cd |
Database: | Directory of Open Access Journals |
ISSN: | 03906078 15928721 |
---|---|
DOI: | 10.3324/haematol.2016.144063 |
Published in: | Haematologica |
Language: | English |